USFDA issues Form 483 with 7 observations to Natco's pharma Hyderabad division
Natco Pharma
on Thursday said the US health regulator has issued a Form 483 with seven observations after inspecting its pharma division in Hyderabad.
The US Food and Drug Administration (USFDA) had conducted an inspection at the company's pharma division located in Kothur, Hyderabad, from June 9-19, 2025, Natco Pharma said in a regulatory filing.
"On conclusion of the inspection, the company received seven observations in the Form-483," it said.
As per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
Natco said it is confident that it will address the observations within the stipulated timeline and remains committed to being cGMP compliant and supplying high-quality products to its customers and patients globally.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Rare earths set to get up to Rs 5,000 crore incentive scheme
India has firmed up a ₹3,500-5,000 crore scheme to incentivise production of rare earth minerals and derived magnets in the country and could be approved in a fortnight, a top government official said. "The priority is to start domestic-critical mineral production in the shortest time period," the official told ET. The sops under the proposed scheme will be offered through a reverse auction process, the official said. The decision to offer incentives for rare earths comes after an internal ministerial review flagged the need for diversification in the wake of acute dependence on Chinese imports. "Fresh steps are being taken to boost domestic availability of critical minerals," he said, adding that at least five large domestic companies had informally expressed keenness to produce these in consultations with the government. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like New Container Houses Vietnam (Prices May Surprise You) Container House | Search ads Search Now Undo China has a near monopoly of the world's supply of rare earth magnets and has curbs on exports. These critical minerals needed in the manufacture of rare earth magnets are crucial for making cars, electric vehicles (EVs) and the renewable energy infrastructure. Industry, particularly the automobile industry, has flagged the detrimental impact of the Chinese curbs and sought government intervention. Beijing in April made a special export licences mandatory for export of seven rare earth elements and related magnets. India's EV and wind turbine makers are the largest demand centres for rare earth elements, cornering over half the entire 4010 metric tonne domestic demand in 2025. Overall demand is expected to more than double to 8220 metric tonnes by 2030. Live Events Besides, the government is also planning an amendment to the Mines and Minerals (Development and Regulation) Act to support the critical mineral mission. Besides regulatory tweaks, the Centre is also expecting commercially viable domestic production of rare earth permanent magnets in small quantities later this year. The ministry of science and technology had sanctioned funding for Midwest Advanced Materials Private Ltd, Hyderabad.
Time of India
3 hours ago
- Time of India
Corporate sector labels Karnataka's call for 10-hr workdays as ‘modern slavery'
The workhour debate has reignited as a proposal by the Karnataka government to extend the daily work hours in certain sectors, including IT, to 10 has triggered widespread backlash online, with many IT professionals and trade unions slamming the move as 'modern-day slavery'. Several took to their social media platforms to voice concerns about employee burnout, declining mental health and the practical difficulties of longer commutes combined with extended work hours. Many have even pointed out that this goes against global trends favouring shorter workweeks and better work-life balance. What happened? The Karnataka government is pushing to amend two laws, aiming to increase the daily work hour cap from nine to ten hours and exempt establishments with less than 10 employees from the Act. Specifically, the proposed changes to the Karnataka Shops and Commercial Establishments Act, 1961, would extend daily working hours to ten and drastically raise the permissible overtime from 50 hours to 144 hours over a three-month period. This could allow employees to work up to 12 hours daily, including overtime.
The Hindu
5 hours ago
- The Hindu
U.S. FDA issues 7 observations to Natco Pharma's formulations unit in Hyderabad
The U.S. Food and Drug Administration (U.S. FDA) has issued seven observations to Natco Pharma's formulations facility in Kothur, Hyderabad. The facility was inspected by the U.S. FDA from June 9-19. On conclusion, the company received seven observations in Form-483, Natco Pharma said on Thursday. The company said it is confident of addressing the observations within the stipulated timeline. 'The company remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally,' Natco Pharma said. The U.S. FDA had in April 2024 issued a warning letter to the facility while raising quality concerns. The action followed an inspection and issue of eight observations in October 2023 by the regulator. The company then said the move may result in delay or withholding of pending product approvals from the site. The facility is for oral solid dosages, including cytotoxic orals; cytotoxic injectables; and pre filled syringes. The focus product categories are oncology, gastroenterology, central nervous system and cardiology. EOM
